Research Objectives

 
Stock Quotes for Research Objectives top ^
  • Industry: Software - Application
  • Sector: Technology
  • Stock Style: Small Core
Sign-up for ocl investment picks

 
News Articles for Research Objectives top ^
2014/9/19
Mackenzie Investments is changing the investment objectives of Mackenzie Canadian Short Term Yield Class Canada NewsWire TORONTO , Sept.
Sign-up for Mackenzie Investments is changing the investment objectives of Mackenzie Canadian Short Term Yield Class investment picks
RGS, a business unit of Avnet, Inc .
Sign-up for RGS Scales Mountains of Big Data with New Object Storage Solution in the Americas investment picks
Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class glaucoma therapies, today announced that it has received a No Objection Letter (“NOL”) from Health Canada to conduct a Phase 3 registration trial of Rhopressa TM , a novel once-daily, triple-action eye drop being tested for its ability to lower intraocular pressure (IOP) in patients with glaucoma or ocular hypertension in Canada.
Sign-up for Aerie Pharmaceuticals, Inc. Receives Health Canada “No Objection Letter” to Commence Phase 3 Registration Trial of RhopressaTM in Patients with Glaucoma in Canada investment picks
WASHINGTON (MarketWatch) -- The Federal Reserve said Wednesday it has no objections to the stress-test capital plan submitted by Bank of America Corp.
Sign-up for UPDATE: Fed has no objections to new Bank of America capital plan investment picks
WASHINGTON (MarketWatch) -- The Federal Reserve said Wednesday it has no objections to the stree-test capital plan submitted by Bank of America Corp.
Sign-up for Fed has no objections to new Bank of America capital plan investment picks
2014/9/9
By Robert Wall and Andy Pasztor Investigators probing the downing of Malaysia Airlines Flight 17 over eastern Ukraine said high-energy objects struck the Boeing Co.
Sign-up for Malaysia Airlines Flight 17 Hit by High-Energy Objects, Report Says -- 3rd Update investment picks
2014/9/9
By Robert Wall and Andy Pasztor Air accident investigators probing the downing of Malaysia Airlines Flight 17 over eastern Ukraine said high-energy objects struck the Boeing 777 and caused the plane to break apart midflight "The initial results of the investigation point towards an external cause of the MH17 crash," said Tjibbe Joustra, chairman of the Dutch Safety Board, which released an interim report on the crash Tuesday.
Sign-up for Malaysia Airlines Flight 17 Hit by High-Energy Objects, Report Says -- Update investment picks
2014/9/9
By Robert Wall and Andy Pasztor Air accident investigators probing the downing of Malaysia Airlines Flight 17 over eastern Ukraine said Tuesday that high-energy objects struck the Boeing 777 and caused the plane to break apart midflight "The initial results of the investigation point towards an external cause of the MH17 crash," Tjibbe Joustra, chairman of the Dutch Safety Board, said in releasing an interim report.
Sign-up for Malaysia Airlines Flight 17 Hit by High Energy Objects, Says Dutch Report investment picks
SALT LAKE CITY , July 28, 2014 /PRNewswire/ -- The Federal Reserve's Board of Governors has notified Zions Bancorporation (NASDAQ: ZION) that it did not object to the capital actions as outlined in its 2014 capital plan, as resubmitted to the Federal Reserve on April 30 , 2014.
Sign-up for Federal Reserve Does Not Object To Zions Bancorporation 2014 Capital Plan investment picks
HAMPTON, N.J., July 18, 2014 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (Nasdaq:CLDX) will release second quarter 2014 financial results on Wednesday, August 6, 2014 after the U.S. financial markets close.
Sign-up for Celldex to Report Second Quarter 2014 Financial Results and Host Corporate 2014 Objectives Update Call investment picks
TE Connectivity (TE), a world leader in connectivity, today announced that it has released Building Information Modeling (BIM) objects for a collection of its most popular copper and fiber enterprise network solutions, making it easy to design new data center and local area network (LAN) projects with exacting accuracy.
Sign-up for TE Connectivity Releases Building Information Modeling Objects to Facilitate Network Design investment picks
Gilead Sciences, Inc. (Nasdaq:GILD) today announced that two Phase 3 clinical trials (Studies 104 and 111) evaluating an investigational once-daily single tablet regimen containing tenofovir alafenamide (TAF) for the treatment of HIV-1 infection in treatment-naïve adults met their primary objectives.
Sign-up for Gilead’s Investigational Tenofovir Alafenamide (TAF)-Based Single Tablet HIV Regimen Meets 48-Week Primary Objective in Two Phase 3 Studies investment picks
2014/9/9
By Robert Wall and Andy Pasztor Air accident investigators probing the downing of Malaysia Airlines Flight 17 over eastern Ukraine published their first definitive account of the accident--drawing from analysis of the plane's onboard cockpit and data recorders and other external sources--but coming to no new conclusions other than definitively stating the plane was shot down.
Sign-up for Malaysia Airlines Flight 17 Hit by High-Energy Objects, Report Says -- 2nd Update investment picks
2014/8/29
Regualtory News: The Board of Directors of Ipsen (Euronext: IPN; ADR: IPSEY), chaired by Marc de Garidel, met on 28 August 2014 to approve the financial statements for the first half 2014, published today.
Sign-up for Ipsen: 2014 Half-Year Results and 2014 Objectives investment picks
2014/9/24
Leiden, The Netherlands, Sept.
Sign-up for Prosensa publishes a sensitive, reproducible and objective methodology for dystrophin analysis in patients with Duchenne muscular dystrophy investment picks

Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Research Objectives
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Research Note  |  Next: Research Offers